🇲🇽 Abreva in Mexico

Abreva (DOCOSANOL) regulatory status in Mexico.

Marketing authorisation

COFEPRIS

  • Status: likely_approved

Abreva in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Dermatology approved in Mexico

Frequently asked questions

Is Abreva approved in Mexico?

Yes. COFEPRIS has authorised it.

Who is the marketing authorisation holder for Abreva in Mexico?

Marketing authorisation holder not available in our data.